DUBLIN, July 19, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Fractional Flow Reserve Market 2016-2020" report to their offering.
The global fractional flow reserve market to grow at a CAGR of 14.14% during the period 2016-2020.
Global Fractional Flow Reserve Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
A trend which is propelling market growth is the rising number of clinical trials and regulatory approvals. There has been a growing trend of clinical trials and regulatory approvals in the market. With the growing demand for fractional flow reserve technology, the new companies are continuously seeking ways to gain approvals and launch new products in the market to improve their market share. In January 2014, ACIST's RXi received 510(k) FDA approval for use in gaining intravascular pressure measurements in the diagnosis and treatment of peripheral artery disease and CAD.
According to the report, a key growth driver is the increased need for diagnosis of coronary artery diseases (CAD). There has been an increased need for a suitable procedure to diagnose the growing prevalence of CAD. Coronary angiography is the standard procedure used for diagnosis of CAD. However, the standard coronary angiography with visual assessment and quantitative coronary angiography alone cannot accurately predict the exact lesion that is causing ischemia.
These methods may not provide the clear picture about the severity and hemodynamic significance of lesions. Several studies state that the coronary angiogram is limited and does not measure the extent to which a stenosis is hampering the blood flow. Therefore, the demand for new diagnosis techniques such as fractional flow reserve has increased.
Further, the report states that one challenge that could impact market growth adversely is the stringent regulatory environment.
- Boston Scientific
- St. Jude Medical
Other prominent vendors
- Abbott Laboratories
- Asahi Intec
- BIOTRONIK international
- GE Healthcare
- Mennen Medical
- Siemens Healthcare
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Cost analysis
Part 06: Market landscape
Part 07: Market segmentation by application
Part 08: Market segmentation by type
Part 09: Geographical segmentation
Part 10: Market drivers
Part 11: Impact of drivers
Part 12: Market challenges
Part 13: Impact of drivers and challenges
Part 14: Market trends
Part 15: Vendor landscape
Part 16: Key vendor analysis
Part 17: Appendix
For more information visit http://www.researchandmarkets.com/research/m6ngvg/global_fractional
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets